NCT07069062 2026-03-09
A Phase I/â…¡ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1/2 Recruiting
Sichuan Huiyu Pharmaceutical Co., Ltd
RemeGen Co., Ltd.
RemeGen Co., Ltd.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Zhejiang Doer Biologics Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Sirnaomics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Beijing Hospital
Beijing Nuokangda Pharmaceutical Technology Co., Ltd.
Livzon Pharmaceutical Group Inc.